Registration number:
trading as
for the Year Ended
Assay Advantage (Vaczine Analytics) Ltd
trading as Assay Advantage Vaccine (Analytics ) Ltd
Contents
Abbreviated Balance Sheet |
|
Notes to the Abbreviated Accounts |
Assay Advantage (Vaczine Analytics) Ltd
trading as Assay Advantage Vaccine (Analytics ) Ltd
(Registration number: 05807728)
Abbreviated Balance Sheet as at 31 March 2016
Note |
2016 |
2015 |
|
Fixed assets |
|||
Intangible assets |
|
|
|
Tangible assets |
|
|
|
|
|
||
Current assets |
|||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Accruals and deferred income |
( |
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Profit and loss account |
|
|
|
Shareholders funds |
|
|
Approved by the Board on
.........................................
Dr JW Savopoulos
Company secretary and director
.........................................
Dr R Savopoulos
Director
Assay Advantage (Vaczine Analytics) Ltd
trading as Assay Advantage Vaccine (Analytics ) Ltd
(Registration number: 05807728)
Abbreviated Balance Sheet as at 31 March 2016
.........................................
Dr JW Savopoulos
Company secretary and director
.........................................
Dr R Savopoulos
Director
Assay Advantage (Vaczine Analytics) Ltd
trading as Assay Advantage Vaccine (Analytics ) Ltd
Notes to the Abbreviated Accounts
Accounting policies |
Basis of preparation
Turnover
Goodwill
Intangible assets
Depreciation
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:
Asset class |
Depreciation method and rate |
Plant and machinery |
|
Computer equipment |
|
Foreign currency
Pensions
Assay Advantage (Vaczine Analytics) Ltd
trading as Assay Advantage Vaccine (Analytics ) Ltd
Notes to the Abbreviated Accounts
Fixed assets |
Intangible assets |
Tangible assets |
Total |
|
Cost |
|||
At 1 April 2015 |
300 |
4,981 |
5,281 |
Additions |
- |
2,197 |
2,197 |
At 31 March 2016 |
300 |
7,178 |
7,478 |
Depreciation |
|||
At 1 April 2015 |
- |
4,841 |
4,841 |
Charge for the year |
- |
772 |
772 |
At 31 March 2016 |
- |
5,613 |
5,613 |
Net book value |
|||
At 31 March 2016 |
|
|
|
At 31 March 2015 |
|
|
|
Share capital |
Allotted, called up and fully paid shares
2016 |
2015 |
|||
No. |
£ |
No. |
£ |
|
|
|
1,000 |
|
1,000 |